Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gentra Systems was a life sciences company specializing in the development and manufacturing of nucleic acid purification systems. The company's core technology focused on the isolation and stabilization of DNA and RNA from various biological samples, including blood, tissue, and plants. Its flagship product line, Puregene, became a gold standard for high-molecular-weight DNA extraction used in large-scale genomic studies and clinical research. Gentra's solutions catered to academic, clinical, and pharmaceutical researchers requiring high-quality genetic material for downstream applications like PCR and sequencing. The company was acquired by QIAGEN in 2006 to strengthen its portfolio in automated and manual sample preparation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gentra Systems.